🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic

PMID: 41901221 · DOI: 10.3390/ph19030374 · Pharmaceuticals (Basel, Switzerland), 2026 · Georgia Watt, Juan Olaya, Gerald Muench, Brett Garner, Tim Karl
Confidence: 0.1 · 5 полей извлечено
Идентификация (6 полей)
Target
0.00
Alt. target
0.00
Protein family
0.00
Functional class
0.00
Subcellular loc.
0.00
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
0.00
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
0.00
Downstream (physiol)
0.00
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
equine mesenchymal stem cells stimulated with lipopolysaccharide
0.90
In vivo
chronic 100 mg/kg cannabidiol treatment in male double transgenic mice; dose-dependent effects of cannabidiol in drinking water in laying hens; lipid absorption and lymphatic transport in rats; administration of WIN55,212-2 in adolescent rats
0.90
In silico
0.00
Genetic association
0.00
Ex vivo
0.00
Animal model
male double transgenic mice; laying hens; rats; adolescent rats
0.90
Diet/model
cannabidiol in drinking water; lipid absorption and lymphatic transport
0.90
Клиника (11 полей)
Drug
Cannabidiol
0.95
Indication
0.00
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
0.00